StockData
Pharvaris N.V. logo

Pharvaris N.V. (PHVS) stock

PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Apr 2, 2026Score 4/30
$31.55−0.73 (-2.26%)

Close on Nov 18, 2026Market cap $2.06BP/E –Yield –

Pharvaris shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Pharvaris's shares outstanding was 68M at Jun 30, 2026. For fiscal 2025 it was 59M, up 9.5% from the year before. The highest annual figure on record is 59M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202559M+9.5%
FY2024Dec 31, 202454M+40.7%
FY2023Dec 31, 202338M+14.3%
FY2022Dec 31, 202234M+10.4%
FY2021Dec 31, 202130M+527.0%
FY2020Dec 31, 20205M0.0%
FY2019Dec 31, 20195M0.0%
FY2018Dec 31, 20185M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202668M+102.7%
Q2 FY2025Jun 30, 202555M+65.1%
Q2 FY2024Jun 30, 202454M–
Q2 FY2023Jun 30, 202335M–
Q2 FY2022Jun 30, 202234M–
Q2 FY2021Jun 30, 202133M–

More Pharvaris figures

See a number that looks wrong?